

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 6.04467473 |
| 2 | negative regulation of T-helper cell differentiation (GO:0045623) | 6.04467473 |
| 3 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.05480422 |
| 4 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.90225543 |
| 5 | endothelium development (GO:0003158) | 4.82231633 |
| 6 | tryptophan catabolic process (GO:0006569) | 4.75297579 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 4.75297579 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 4.75297579 |
| 9 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 4.65889361 |
| 10 | positive regulation of vasculogenesis (GO:2001214) | 4.64008762 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 4.29918640 |
| 12 | regulation of memory T cell differentiation (GO:0043380) | 4.29323612 |
| 13 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 4.15580219 |
| 14 | indolalkylamine metabolic process (GO:0006586) | 4.13148359 |
| 15 | purine deoxyribonucleotide metabolic process (GO:0009151) | 4.11852669 |
| 16 | definitive hemopoiesis (GO:0060216) | 4.06845838 |
| 17 | tryptophan metabolic process (GO:0006568) | 4.05541937 |
| 18 | cellular response to ATP (GO:0071318) | 3.93194333 |
| 19 | regulation of female gonad development (GO:2000194) | 3.87110907 |
| 20 | regulation of B cell apoptotic process (GO:0002902) | 3.85852342 |
| 21 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.84347804 |
| 22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.83705547 |
| 23 | regulation of germinal center formation (GO:0002634) | 3.75329807 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 3.69622306 |
| 25 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.69096942 |
| 26 | protein localization to Golgi apparatus (GO:0034067) | 3.64794713 |
| 27 | mature B cell differentiation involved in immune response (GO:0002313) | 3.63283649 |
| 28 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.55597508 |
| 29 | negative regulation of B cell apoptotic process (GO:0002903) | 3.49619755 |
| 30 | purine nucleotide salvage (GO:0032261) | 3.49144792 |
| 31 | adenosine metabolic process (GO:0046085) | 3.46287930 |
| 32 | interkinetic nuclear migration (GO:0022027) | 3.36162996 |
| 33 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.34159382 |
| 34 | Peyers patch development (GO:0048541) | 3.34159382 |
| 35 | cell differentiation involved in metanephros development (GO:0072202) | 3.33182830 |
| 36 | L-fucose metabolic process (GO:0042354) | 3.27714485 |
| 37 | L-fucose catabolic process (GO:0042355) | 3.27714485 |
| 38 | fucose catabolic process (GO:0019317) | 3.27714485 |
| 39 | regulation of vasculogenesis (GO:2001212) | 3.27451613 |
| 40 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24508129 |
| 41 | cellular response to exogenous dsRNA (GO:0071360) | 3.22639260 |
| 42 | amino acid salvage (GO:0043102) | 3.21091412 |
| 43 | L-methionine salvage (GO:0071267) | 3.21091412 |
| 44 | L-methionine biosynthetic process (GO:0071265) | 3.21091412 |
| 45 | response to vitamin E (GO:0033197) | 3.19305571 |
| 46 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.16999657 |
| 47 | regulation of T-helper 1 type immune response (GO:0002825) | 3.05936068 |
| 48 | parturition (GO:0007567) | 3.05725615 |
| 49 | C4-dicarboxylate transport (GO:0015740) | 3.04151316 |
| 50 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.03427886 |
| 51 | axoneme assembly (GO:0035082) | 3.01029237 |
| 52 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.99535714 |
| 53 | carnitine transport (GO:0015879) | 2.98655804 |
| 54 | amino-acid betaine transport (GO:0015838) | 2.98655804 |
| 55 | positive regulation of defense response to virus by host (GO:0002230) | 2.96727267 |
| 56 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.95573053 |
| 57 | energy homeostasis (GO:0097009) | 2.93458652 |
| 58 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.89510567 |
| 59 | inositol phosphate dephosphorylation (GO:0046855) | 2.89510567 |
| 60 | carnitine transmembrane transport (GO:1902603) | 2.88130698 |
| 61 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.85718933 |
| 62 | GMP metabolic process (GO:0046037) | 2.85568377 |
| 63 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.85405582 |
| 64 | amine catabolic process (GO:0009310) | 2.82423180 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 2.82423180 |
| 66 | indole-containing compound metabolic process (GO:0042430) | 2.80766748 |
| 67 | negative regulation of cytokine secretion (GO:0050710) | 2.79836461 |
| 68 | cytochrome complex assembly (GO:0017004) | 2.79743307 |
| 69 | inositol phosphate catabolic process (GO:0071545) | 2.78663734 |
| 70 | parental behavior (GO:0060746) | 2.76180832 |
| 71 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.76047724 |
| 72 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75507455 |
| 73 | angiogenesis involved in wound healing (GO:0060055) | 2.73861982 |
| 74 | mature B cell differentiation (GO:0002335) | 2.70174429 |
| 75 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.69651661 |
| 76 | negative regulation of protein oligomerization (GO:0032460) | 2.68341742 |
| 77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66616418 |
| 78 | histamine secretion (GO:0001821) | 2.66238615 |
| 79 | B cell mediated immunity (GO:0019724) | 2.65460926 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 2.64858036 |
| 81 | DNA deamination (GO:0045006) | 2.64152138 |
| 82 | protein localization to peroxisome (GO:0072662) | 2.63924256 |
| 83 | protein targeting to peroxisome (GO:0006625) | 2.63924256 |
| 84 | establishment of protein localization to peroxisome (GO:0072663) | 2.63924256 |
| 85 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.62868828 |
| 86 | negative regulation of telomere maintenance (GO:0032205) | 2.62818240 |
| 87 | nitric oxide mediated signal transduction (GO:0007263) | 2.62068258 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61808262 |
| 89 | inositol metabolic process (GO:0006020) | 2.60779214 |
| 90 | positive regulation of steroid hormone secretion (GO:2000833) | 2.58504631 |
| 91 | aromatic amino acid family catabolic process (GO:0009074) | 2.58283814 |
| 92 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.57872935 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.57382113 |
| 94 | monoamine transport (GO:0015844) | 2.55143044 |
| 95 | rRNA catabolic process (GO:0016075) | 2.54485193 |
| 96 | negative regulation of type 2 immune response (GO:0002829) | 2.53884574 |
| 97 | aggressive behavior (GO:0002118) | 2.53480870 |
| 98 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.51222136 |
| 99 | regulation of collateral sprouting (GO:0048670) | 2.49076184 |
| 100 | response to pheromone (GO:0019236) | 2.48955318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.80442215 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.55300071 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 4.52309840 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90799509 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.70622848 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60066336 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.54869067 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.47823297 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.42117600 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35777559 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.34156764 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33749294 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.31568358 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24794860 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15356245 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.10036976 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.78383582 |
| 18 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66345252 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64355247 |
| 20 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.63765887 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58882228 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.54810769 |
| 23 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.53953410 |
| 24 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.53953410 |
| 25 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53570325 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53570325 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51819055 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.51344678 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51271285 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50859973 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48351993 |
| 32 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.48034020 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47129905 |
| 34 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.44614959 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34562238 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34264497 |
| 37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34240200 |
| 38 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.30890484 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30620901 |
| 40 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30620901 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26583780 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26387085 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25944893 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.23950259 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23223025 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23217127 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22565431 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22391993 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22051860 |
| 50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.21628439 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20931917 |
| 52 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20752470 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20026397 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18828816 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18794786 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17353783 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17039423 |
| 58 | AR_20517297_ChIP-Seq_VCAP_Human | 1.16599594 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.16417634 |
| 60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14908088 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.13127718 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12973135 |
| 63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11367927 |
| 64 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10045020 |
| 65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09856438 |
| 66 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09434845 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07660724 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07035389 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06230532 |
| 70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05648795 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05324417 |
| 72 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05187967 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04493136 |
| 74 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03556632 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03496886 |
| 76 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03441468 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01665047 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01160840 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00722405 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99119968 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99096821 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99002902 |
| 83 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97681162 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96656977 |
| 85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96628410 |
| 86 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96169640 |
| 87 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95355570 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95229615 |
| 89 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94837965 |
| 90 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94102131 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94091636 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93345705 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93025977 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92865843 |
| 95 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92480945 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91354744 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90569357 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89495648 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87560314 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86860443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 3.71396771 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.68844838 |
| 3 | MP0003787_abnormal_imprinting | 3.65925840 |
| 4 | MP0003195_calcinosis | 3.27530209 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.02696375 |
| 6 | MP0004147_increased_porphyrin_level | 2.72294935 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.64175100 |
| 8 | MP0009278_abnormal_bone_marrow | 2.57644455 |
| 9 | MP0006054_spinal_hemorrhage | 2.52369838 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.49946570 |
| 11 | MP0005451_abnormal_body_composition | 2.45975570 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.39828964 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.17224168 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.17224168 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.10001106 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.07108428 |
| 17 | MP0001188_hyperpigmentation | 1.83972273 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 1.83330528 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 1.77437289 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 1.74363169 |
| 21 | MP0002127_abnormal_cardiovascular_syste | 1.74361487 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.74316633 |
| 23 | MP0003252_abnormal_bile_duct | 1.67735317 |
| 24 | MP0003122_maternal_imprinting | 1.59609360 |
| 25 | MP0001764_abnormal_homeostasis | 1.50258938 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.48234114 |
| 27 | MP0001727_abnormal_embryo_implantation | 1.46957683 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.43552537 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.43514255 |
| 30 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43492867 |
| 31 | MP0008872_abnormal_physiological_respon | 1.42255763 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.41811150 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.39703942 |
| 34 | MP0005535_abnormal_body_temperature | 1.38595597 |
| 35 | MP0000631_abnormal_neuroendocrine_gland | 1.38495373 |
| 36 | MP0003724_increased_susceptibility_to | 1.37053294 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.36085807 |
| 38 | MP0006292_abnormal_olfactory_placode | 1.34490087 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.29534539 |
| 40 | MP0008004_abnormal_stomach_pH | 1.28842108 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.28605351 |
| 42 | MP0002928_abnormal_bile_duct | 1.26504835 |
| 43 | MP0009697_abnormal_copulation | 1.24549325 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.23813806 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.19982970 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 1.18413818 |
| 47 | MP0000230_abnormal_systemic_arterial | 1.17069580 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.16807639 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.16758552 |
| 50 | MP0002132_abnormal_respiratory_system | 1.16298750 |
| 51 | MP0009764_decreased_sensitivity_to | 1.15795823 |
| 52 | MP0001790_abnormal_immune_system | 1.13482840 |
| 53 | MP0005387_immune_system_phenotype | 1.13482840 |
| 54 | MP0005410_abnormal_fertilization | 1.13263433 |
| 55 | MP0002254_reproductive_system_inflammat | 1.11270683 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.06849578 |
| 57 | MP0001944_abnormal_pancreas_morphology | 1.05758544 |
| 58 | MP0003283_abnormal_digestive_organ | 1.03665064 |
| 59 | MP0005448_abnormal_energy_balance | 1.02826039 |
| 60 | MP0003011_delayed_dark_adaptation | 1.02799378 |
| 61 | MP0001905_abnormal_dopamine_level | 1.00921583 |
| 62 | MP0003121_genomic_imprinting | 0.99965774 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.99416162 |
| 64 | MP0003646_muscle_fatigue | 0.98745065 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 0.98016022 |
| 66 | MP0003123_paternal_imprinting | 0.95853061 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.94120865 |
| 68 | MP0000681_abnormal_thyroid_gland | 0.92561803 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.92479812 |
| 70 | MP0008873_increased_physiological_sensi | 0.89733346 |
| 71 | MP0005365_abnormal_bile_salt | 0.89461587 |
| 72 | MP0010386_abnormal_urinary_bladder | 0.89442197 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.87824238 |
| 74 | MP0004084_abnormal_cardiac_muscle | 0.86282216 |
| 75 | MP0010155_abnormal_intestine_physiology | 0.85936988 |
| 76 | MP0000516_abnormal_urinary_system | 0.85489441 |
| 77 | MP0005367_renal/urinary_system_phenotyp | 0.85489441 |
| 78 | MP0005253_abnormal_eye_physiology | 0.81364450 |
| 79 | MP0001968_abnormal_touch/_nociception | 0.79232531 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.78774140 |
| 81 | MP0000685_abnormal_immune_system | 0.78037299 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.76469068 |
| 83 | MP0009046_muscle_twitch | 0.76409513 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.76348736 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.75676668 |
| 86 | MP0001191_abnormal_skin_condition | 0.75221906 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.74946228 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.74746404 |
| 89 | MP0002933_joint_inflammation | 0.73247726 |
| 90 | MP0002398_abnormal_bone_marrow | 0.73128016 |
| 91 | MP0002163_abnormal_gland_morphology | 0.72568890 |
| 92 | MP0005310_abnormal_salivary_gland | 0.70158169 |
| 93 | MP0003718_maternal_effect | 0.69978358 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.69388994 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.69232770 |
| 96 | MP0004085_abnormal_heartbeat | 0.68135170 |
| 97 | MP0003045_fibrosis | 0.67873512 |
| 98 | MP0001800_abnormal_humoral_immune | 0.67482667 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 0.67286994 |
| 100 | MP0002723_abnormal_immune_serum | 0.66687167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metaphyseal dysplasia (HP:0100255) | 4.91466828 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.64210083 |
| 3 | Neonatal respiratory distress (HP:0002643) | 3.80891387 |
| 4 | Stomach cancer (HP:0012126) | 3.71059824 |
| 5 | Hypoglycemic coma (HP:0001325) | 3.70551870 |
| 6 | Symptomatic seizures (HP:0011145) | 3.51671047 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.27176936 |
| 8 | Abnormality of the costochondral junction (HP:0000919) | 3.25056382 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.23025104 |
| 10 | Abnormality of the periventricular white matter (HP:0002518) | 3.21529209 |
| 11 | Abnormality of B cell number (HP:0010975) | 3.17502463 |
| 12 | Progressive microcephaly (HP:0000253) | 3.05283108 |
| 13 | Mesangial abnormality (HP:0001966) | 3.01107671 |
| 14 | Polydipsia (HP:0001959) | 3.00768411 |
| 15 | Abnormal drinking behavior (HP:0030082) | 3.00768411 |
| 16 | Facial diplegia (HP:0001349) | 2.92049228 |
| 17 | Neoplasm of the adrenal cortex (HP:0100641) | 2.91586287 |
| 18 | Attenuation of retinal blood vessels (HP:0007843) | 2.89528535 |
| 19 | Pancreatic cysts (HP:0001737) | 2.85331511 |
| 20 | Stomatitis (HP:0010280) | 2.79156253 |
| 21 | Severe muscular hypotonia (HP:0006829) | 2.79093324 |
| 22 | Brushfield spots (HP:0001088) | 2.77627049 |
| 23 | Congenital stationary night blindness (HP:0007642) | 2.75217749 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.69489023 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 2.68488382 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.58352322 |
| 27 | Progressive inability to walk (HP:0002505) | 2.55951702 |
| 28 | B lymphocytopenia (HP:0010976) | 2.54416588 |
| 29 | Enlarged epiphyses (HP:0010580) | 2.51416811 |
| 30 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51304248 |
| 31 | Polyuria (HP:0000103) | 2.49434225 |
| 32 | Acute lymphatic leukemia (HP:0006721) | 2.48413201 |
| 33 | Ketoacidosis (HP:0001993) | 2.37320018 |
| 34 | Adrenal hypoplasia (HP:0000835) | 2.21759539 |
| 35 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.20447189 |
| 36 | Intellectual disability, profound (HP:0002187) | 2.19348639 |
| 37 | Medial flaring of the eyebrow (HP:0010747) | 2.18660344 |
| 38 | Tubular atrophy (HP:0000092) | 2.16897247 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.15101838 |
| 40 | Acute myeloid leukemia (HP:0004808) | 2.15054379 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.14478831 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.12955973 |
| 43 | Hepatic necrosis (HP:0002605) | 2.10558204 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.10197476 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.09357744 |
| 46 | Hyperphosphatemia (HP:0002905) | 2.08858945 |
| 47 | Increased corneal curvature (HP:0100692) | 2.07879608 |
| 48 | Keratoconus (HP:0000563) | 2.07879608 |
| 49 | Abnormality of renal excretion (HP:0011036) | 2.06994005 |
| 50 | Decreased central vision (HP:0007663) | 2.06018764 |
| 51 | Limb hypertonia (HP:0002509) | 2.05410822 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.03730303 |
| 53 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.03691863 |
| 54 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.02703074 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.02201144 |
| 56 | Thyroiditis (HP:0100646) | 1.98367843 |
| 57 | Abnormal pancreas size (HP:0012094) | 1.97623774 |
| 58 | Abnormal urine output (HP:0012590) | 1.95871020 |
| 59 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91968999 |
| 60 | Tachypnea (HP:0002789) | 1.90766162 |
| 61 | Hypoproteinemia (HP:0003075) | 1.90004075 |
| 62 | Enlarged penis (HP:0000040) | 1.89465111 |
| 63 | Hyperglycemia (HP:0003074) | 1.88113094 |
| 64 | Myositis (HP:0100614) | 1.87504251 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86700625 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 1.86700625 |
| 67 | Papilledema (HP:0001085) | 1.85713667 |
| 68 | Cystic liver disease (HP:0006706) | 1.83226816 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 1.82692146 |
| 70 | Abnormality of T cell physiology (HP:0011840) | 1.82626477 |
| 71 | Renal cortical cysts (HP:0000803) | 1.82260236 |
| 72 | Abnormality of the pubic bones (HP:0003172) | 1.81549586 |
| 73 | Asplenia (HP:0001746) | 1.80243784 |
| 74 | Poor speech (HP:0002465) | 1.78537453 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76076524 |
| 76 | Abnormality of macular pigmentation (HP:0008002) | 1.75745078 |
| 77 | Macroorchidism (HP:0000053) | 1.74864190 |
| 78 | Disproportionate short-trunk short stature (HP:0003521) | 1.74545050 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 1.74473737 |
| 80 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.73610584 |
| 81 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73610584 |
| 82 | Thrombocytosis (HP:0001894) | 1.73585481 |
| 83 | Nephronophthisis (HP:0000090) | 1.72257695 |
| 84 | Abnormality of dental color (HP:0011073) | 1.70738878 |
| 85 | Absent/shortened dynein arms (HP:0200106) | 1.70275899 |
| 86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70275899 |
| 87 | Clonus (HP:0002169) | 1.70007710 |
| 88 | Type II lissencephaly (HP:0007260) | 1.69852388 |
| 89 | Poor eye contact (HP:0000817) | 1.69536322 |
| 90 | Ketosis (HP:0001946) | 1.68239144 |
| 91 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.67126642 |
| 92 | Spastic paraparesis (HP:0002313) | 1.66617277 |
| 93 | Alveolar cell carcinoma (HP:0006519) | 1.66515900 |
| 94 | Congenital primary aphakia (HP:0007707) | 1.66456971 |
| 95 | Submucous cleft hard palate (HP:0000176) | 1.65444055 |
| 96 | Abnormal epiphyseal ossification (HP:0010656) | 1.65295815 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64826829 |
| 98 | Agitation (HP:0000713) | 1.64482091 |
| 99 | Thin bony cortex (HP:0002753) | 1.63427396 |
| 100 | Inability to walk (HP:0002540) | 1.62721582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 5.25405683 |
| 2 | FRK | 4.30124065 |
| 3 | AKT3 | 4.04661046 |
| 4 | TAOK3 | 3.28329270 |
| 5 | MAPKAPK3 | 3.23804624 |
| 6 | KIT | 3.04474508 |
| 7 | FLT3 | 2.90933476 |
| 8 | TIE1 | 2.66425313 |
| 9 | ADRBK2 | 2.19615066 |
| 10 | MAP4K2 | 2.12299862 |
| 11 | CCNB1 | 2.05002089 |
| 12 | PINK1 | 2.00392558 |
| 13 | BMPR2 | 1.93276445 |
| 14 | NUAK1 | 1.90237722 |
| 15 | DYRK3 | 1.86736187 |
| 16 | TEC | 1.73811540 |
| 17 | MAP4K1 | 1.68253480 |
| 18 | JAK3 | 1.64129959 |
| 19 | INSRR | 1.58884663 |
| 20 | RIPK4 | 1.56389151 |
| 21 | GRK1 | 1.50308831 |
| 22 | MKNK2 | 1.46410931 |
| 23 | CSF1R | 1.41145188 |
| 24 | DAPK2 | 1.40735304 |
| 25 | BMPR1B | 1.32678073 |
| 26 | PIK3CG | 1.29771978 |
| 27 | CSNK1G3 | 1.28436379 |
| 28 | EIF2AK3 | 1.25650677 |
| 29 | MAP3K4 | 1.22155199 |
| 30 | KDR | 1.20970177 |
| 31 | ITK | 1.20598440 |
| 32 | ACVR1B | 1.17714123 |
| 33 | CSNK1G1 | 1.14498729 |
| 34 | CDC7 | 1.05332411 |
| 35 | MKNK1 | 1.05106368 |
| 36 | DAPK1 | 1.00158229 |
| 37 | SYK | 0.99457745 |
| 38 | CSNK1A1L | 0.95425021 |
| 39 | CSNK1G2 | 0.94864261 |
| 40 | HIPK2 | 0.93482628 |
| 41 | PTK2B | 0.93185637 |
| 42 | TLK1 | 0.91914691 |
| 43 | BLK | 0.90333131 |
| 44 | PASK | 0.90012722 |
| 45 | SGK2 | 0.89779564 |
| 46 | MAPK13 | 0.86791698 |
| 47 | BCKDK | 0.83393520 |
| 48 | BRAF | 0.79257020 |
| 49 | MAP2K7 | 0.77668422 |
| 50 | OXSR1 | 0.76230817 |
| 51 | MAP3K6 | 0.74100305 |
| 52 | SCYL2 | 0.72821681 |
| 53 | TNK2 | 0.71555078 |
| 54 | NTRK3 | 0.69909020 |
| 55 | FES | 0.69373294 |
| 56 | PRKG2 | 0.68974975 |
| 57 | MAP3K2 | 0.68922686 |
| 58 | PRKCQ | 0.68128960 |
| 59 | TNIK | 0.67371121 |
| 60 | PRKCE | 0.66597295 |
| 61 | PHKG1 | 0.65980164 |
| 62 | PHKG2 | 0.65980164 |
| 63 | TRPM7 | 0.64375536 |
| 64 | LCK | 0.63514363 |
| 65 | MAP2K6 | 0.61777388 |
| 66 | GRK6 | 0.56868401 |
| 67 | VRK2 | 0.56405116 |
| 68 | IKBKB | 0.55885805 |
| 69 | TGFBR1 | 0.55489991 |
| 70 | LYN | 0.53753794 |
| 71 | TBK1 | 0.52657786 |
| 72 | BTK | 0.51445126 |
| 73 | FER | 0.50893126 |
| 74 | IKBKE | 0.50285656 |
| 75 | STK39 | 0.47366855 |
| 76 | ADRBK1 | 0.47093880 |
| 77 | WNK3 | 0.46850748 |
| 78 | PLK4 | 0.43795108 |
| 79 | CLK1 | 0.43428805 |
| 80 | SGK494 | 0.43130592 |
| 81 | SGK223 | 0.43130592 |
| 82 | MAP3K14 | 0.40771169 |
| 83 | TTK | 0.39731973 |
| 84 | PIM1 | 0.39447015 |
| 85 | SGK3 | 0.37713499 |
| 86 | TXK | 0.37657429 |
| 87 | MAP2K4 | 0.35792835 |
| 88 | FGFR2 | 0.35061428 |
| 89 | NLK | 0.34575865 |
| 90 | PLK3 | 0.34239412 |
| 91 | PRKD3 | 0.33068504 |
| 92 | PRKAA2 | 0.30963885 |
| 93 | MATK | 0.30753682 |
| 94 | CSNK1A1 | 0.30241166 |
| 95 | PLK2 | 0.29330136 |
| 96 | IRAK1 | 0.29139652 |
| 97 | IGF1R | 0.28052508 |
| 98 | ABL1 | 0.27725204 |
| 99 | PRKCA | 0.27412798 |
| 100 | RPS6KA5 | 0.27161875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Selenocompound metabolism_Homo sapiens_hsa00450 | 4.66420977 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.83324776 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.37218524 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.26452001 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.88654957 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.86192363 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.74597838 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.34874679 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30563249 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.29872058 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20128168 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08243867 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94398135 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.92706135 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.59051606 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54851619 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.54251589 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43089903 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.39665414 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.38116964 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36750047 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34191477 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33603426 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29580707 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28439823 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25021804 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24882527 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23144420 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19129339 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17471898 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.09250337 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05696555 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01556895 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99954944 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99357976 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99074566 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97462106 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96891296 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96598068 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95694566 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94599347 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94514282 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92182287 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88894845 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88136341 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87913245 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 0.86462618 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 0.85681362 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85208044 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.85125383 |
| 51 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84434803 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84068583 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82796473 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80417760 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79576704 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78989503 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78818927 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77742431 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.75548656 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74531661 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72827204 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 0.71673688 |
| 63 | Salivary secretion_Homo sapiens_hsa04970 | 0.70423968 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68832399 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.67472031 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.65799528 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64695694 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63973091 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.62871474 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.62777490 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61739301 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60703733 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60367354 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58775971 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57663674 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56071696 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.55694311 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54388864 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53543838 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51400136 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51173097 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49899376 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47645670 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.47443449 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46448771 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45668148 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43814621 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39311084 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.38580000 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37959631 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36166251 |
| 92 | Proteasome_Homo sapiens_hsa03050 | 0.36007312 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34194794 |
| 94 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33393011 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33196438 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27381501 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27258724 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26013056 |
| 99 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.24852856 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24079317 |

